rs281875275
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM1PM2PP3_ModeratePP5
The NM_000128.4(F11):c.1693G>A(p.Glu565Lys) variant causes a missense change. The variant allele was found at a frequency of 0.00000558 in 1,613,106 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000128.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
F11 | ENST00000403665.7 | c.1693G>A | p.Glu565Lys | missense_variant | Exon 14 of 15 | 1 | NM_000128.4 | ENSP00000384957.2 | ||
F11-AS1 | ENST00000505103.5 | n.1005+628C>T | intron_variant | Intron 3 of 3 | 1 | |||||
F11 | ENST00000264691.4 | c.292G>A | p.Glu98Lys | missense_variant | Exon 2 of 3 | 3 | ENSP00000264691.4 | |||
F11 | ENST00000503841.1 | n.212G>A | non_coding_transcript_exon_variant | Exon 1 of 2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152096Hom.: 0 Cov.: 30
GnomAD4 exome AF: 0.00000479 AC: 7AN: 1461010Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 2AN XY: 726852
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152096Hom.: 0 Cov.: 30 AF XY: 0.0000135 AC XY: 1AN XY: 74290
ClinVar
Submissions by phenotype
Hereditary factor XI deficiency disease Pathogenic:2
- -
- -
not specified Uncertain:1
Variant summary: F11 c.1693G>A (p.Glu565Lys) results in a conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. 4/4 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. One study reported that this variant causes skipping of exon 14 however the results as presented do not allow a conclusive determination supporting this conclusion (Zucker_20011). The variant was absent in 251488 control chromosomes. c.1693G>A has been reported in the literature as a non-informative genotype (second allele not specified), a homozygous genotype (one report) and as a presumed compound heterozygous genotype (one report) in individuals affected with features of factor XI deficiency disease or in settings of multigene panel testing for coagulation disorders (example, Hill_2005, Qulin_2009, Karimi_2009, Zucker_2011, Rimoldi_2018, Downes_2019). These data indicate that the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 31064749, 15953011, 18758779, 20523169, 29178608, 21718436). One group has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation and classified the variant as likely pathogenic. Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. -
not provided Other:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at